Evidence map

ArticleThe European journal of health economics : HEPAC : health economics in prevention and care2023

The long-term cost-effectiveness of once-weekly semaglutide 1 mg vs. dulaglutide 3 mg and 4.5 mg in the UK.

Adie Viljoen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

3 papers cite it

2023
2024
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 36114904